Apogee Therapeutics (APGE) Stock Chart & Stock Price History $38.13 +0.17 (+0.45%) Closing price 04:00 PM EasternExtended Trading$38.11 -0.02 (-0.05%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Apogee Therapeutics Stock Price Performance The Apogee Therapeutics (APGE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 33.92%, with a year-to-date return of -15.83%. In the past month, the stock has decreased 0.37%, reflecting recent market activity. As of the latest close, Apogee Therapeutics traded at $37.96 with a market cap of $1.75 billion and volume of 530,084 shares. Receive APGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.78%1 Month Performance-0.37%3 Month Performance-7.79%Year-To-Date Performance-15.83%1 Year Performance-33.92% APGE Stock Chart for Tuesday, September, 23, 2025 APGE Chart by TradingView Apogee Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/23/2025$37.96$38.13+0.45%$38.55$37.30348,460 shs$1.76 billion09/22/2025$36.53$37.96+3.91%$38.21$35.39530,084 shs$1.75 billion09/19/2025$38.43$36.53-4.94%$38.48$36.451.51 million shs$1.68 billion09/18/2025$37.63$38.43+2.13%$38.88$37.91480,576 shs$1.77 billion09/17/2025$36.84$37.63+2.14%$39.15$37.01446,667 shs$1.74 billion09/16/2025$36.86$36.84-0.05%$37.87$36.28337,954 shs$1.70 billion09/15/2025$36.88$36.86-0.05%$37.97$36.01494,212 shs$1.70 billion09/12/2025$37.27$36.88-1.05%$37.94$36.86474,539 shs$1.70 billion09/11/2025$37.49$37.27-0.59%$38.39$36.81724,793 shs$1.72 billion09/10/2025$38.46$37.49-2.52%$38.75$37.431.03 million shs$1.73 billion09/09/2025$38.42$38.46+0.10%$38.84$37.68688,108 shs$1.77 billion09/08/2025$37.87$38.42+1.45%$38.81$37.51682,484 shs$1.77 billion09/05/2025$37.13$37.87+1.99%$38.21$36.39498,293 shs$1.75 billion09/04/2025$38.16$37.13-2.70%$38.37$36.68386,855 shs$1.71 billion09/03/2025$37.86$38.16+0.79%$38.75$36.73380,597 shs$1.75 billion09/02/2025$36.37$37.86+4.10%$38.00$36.00366,994 shs$1.75 billion09/01/2025$36.37$36.37$37.35$35.68516,522 shs$1.68 billion08/29/2025$36.62$36.37-0.68%$37.35$35.68516,522 shs$1.68 billion08/28/2025$37.79$36.62-3.10%$38.25$36.39389,711 shs$1.69 billion08/27/2025$37.87$37.79-0.21%$38.46$37.47272,791 shs$1.74 billion08/26/2025$36.94$37.87+2.52%$37.97$36.64322,959 shs$1.75 billion08/25/2025$38.27$36.94-3.48%$38.38$36.78241,116 shs$1.70 billion08/22/2025$36.35$38.27+5.28%$38.88$36.42644,589 shs$1.76 billion Related Companies GRFS Stock Chart RYTM Stock Chart ABVX Stock Chart CYTK Stock Chart LEGN Stock Chart AXSM Stock Chart NUVL Stock Chart RNA Stock Chart MRUS Stock Chart CRSP Stock Chart Receive APGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APGE) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APGE Stock Alerts